Fusion Antibodies (LSE:FAB) Equity-to-Asset : 0.71 (As of Sep. 2023)

Fusion Antibodies Equity-to-Asset Chart

Fusion Antibodies Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Equity-to-Asset		Get a 7-Day Free Trial				0.86	0.80	0.81	0.75	0.55

Fusion Antibodies Semi-Annual Data
	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Equity-to-Asset	Get a 7-Day Free Trial											0.79	0.75	0.65	0.55	0.71

Competitive Comparison of Fusion Antibodies's Equity-to-Asset

For the Biotechnology subindustry, Fusion Antibodies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Antibodies's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's Equity-to-Asset falls into.

Fusion Antibodies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Fusion Antibodies's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Fusion Antibodies's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fusion Antibodies  (LSE:FAB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Fusion Antibodies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Antibodies (LSE:FAB) Business Description